ProCE Banner Activity

Expert Management of Treatment-Related Adverse Events From BCL-2 Inhibitors

Slideset

In these downloadable slides, experts discuss key considerations in the management of adverse events secondary to BCL-2 inhibitor therapy.

Released: September 30, 2024

Expiration: October 01, 2025

Share

Faculty

Courtney DiNardo

Courtney DiNardo, MD, MSCE

Professor of Medicine
Department of Leukemia
University of Texas MD Anderson Cancer Center
Houston, Texas

Caitlin R. Rausch

Caitlin R. Rausch, PharmD, BCOP

Clinical Pharmacy Specialist, Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AbbVie Inc.

AbbVie Inc.